PPA-037 is an orally active and highly selective inhibitor of cyclin-dependent kinase 12 (CDK12). It induces the degradation of Cyclin K, thereby enhancing antiproliferative effects on tumor cells. PPA-037 holds potential for use in cancer research.
Molecular Weight:
425.53
CAS Number:
[2883700-83-0]
Formula:
C25H27N7
Target:
CDK
T207610
* VAT and and shipping costs not included. Errors and price changes excepted
